89bio (NASDAQ: ETNB)
2 known investors
89bio is a clinical-stage biopharmaceutical company developing therapies for patients with liver and cardiometabolic diseases.
Investors · 2
Frequently asked questions
- What does 89bio (NASDAQ: ETNB) do?
- 89bio is a clinical-stage biopharmaceutical company developing therapies for patients with liver and cardiometabolic diseases.
- Who are 89bio (NASDAQ: ETNB)'s investors?
- 89bio (NASDAQ: ETNB)'s investors include K2 HealthVentures, Longitude Capital.